Novozymes A/S – (NVZMY) Now Covered by Deutsche Bank AG
Equities researchers at Deutsche Bank AG started coverage on shares of Novozymes A/S – (NASDAQ:NVZMY) in a note issued to investors on Friday, The Fly reports. The firm set a “hold” rating on the stock.
A number of other research analysts have also weighed in on NVZMY. Zacks Investment Research lowered shares of Novozymes A/S – from a “buy” rating to a “hold” rating in a research note on Wednesday, June 22nd. Berenberg Bank initiated coverage on shares of Novozymes A/S – in a research note on Tuesday, September 27th. They issued a “sell” rating on the stock.
Shares of Novozymes A/S – (NASDAQ:NVZMY) traded down 0.102% during mid-day trading on Friday, reaching $43.995. The company’s stock had a trading volume of 16,971 shares. The stock has a market cap of $13.22 billion and a P/E ratio of 30.616. Novozymes A/S – has a one year low of $37.98 and a one year high of $49.55. The stock has a 50 day moving average of $43.63 and a 200-day moving average of $46.07.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/07/novozymes-as-nvzmy-now-covered-by-deutsche-bank-ag-2.html
About Novozymes A/S –
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.
Receive News & Ratings for Novozymes A/S - Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S - and related companies with MarketBeat.com's FREE daily email newsletter.